Filing Flows › Travere Therapeutics (TVTX) › Who owns the stock
Who owns Travere Therapeutics (TVTX) stock
301 funds reported Travere Therapeutics (TVTX) shares in their latest 13F filings, worth $6.5B in all. The largest holder is Jupiter Topco LLC ($643M). Last quarter 191 funds added to their stakes and 103 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Jupiter Topco LLC | 11,324,191 | $643M | base | 2026-06-30 |
| BlackRock | 8,020,663 | $456M | increase | 2026-06-30 |
| FMR LLC | 7,096,614 | $403M | decrease | 2026-06-30 |
| Janus Henderson Group | 11,419,586 | $339M | increase | 2026-03-31 |
| Bank of America | 4,568,341 | $260M | increase | 2026-06-30 |
| State Street | 4,256,224 | $242M | decrease | 2026-06-30 |
| Vanguard Group | 6,309,229 | $241M | decrease | 2025-12-31 |
| Vanguard Capital Management LLC | 4,108,694 | $233M | increase | 2026-06-30 |
| Perceptive Advisors LLC | 3,752,574 | $213M | decrease | 2026-06-30 |
| Nomura Asset Management International | 2,812,514 | $160M | decrease | 2026-06-30 |
| Adage Capital Partners GP, L.L.C. | 2,569,356 | $146M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 2,371,887 | $135M | increase | 2026-06-30 |
| Rock Springs Capital Management LP | 2,179,069 | $124M | increase | 2026-06-30 |
| Kynam Capital Management, LP | 2,000,000 | $114M | increase | 2026-06-30 |
| Stephens Investment Management Group LLC | 1,875,304 | $107M | increase | 2026-06-30 |
Travere Therapeutics' latest quarter
Travere Therapeutics, Q3 2026: revenue $225M (+36% year over year), operating margin -30.3%, net loss $52.3M, operating cash flow $98.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most TVTX stock?
By the latest 13F filings: Jupiter Topco LLC ($643M); BlackRock ($456M); FMR LLC ($403M); Janus Henderson Group ($339M); Bank of America ($260M).
What is the short interest in TVTX?
10,913,583 shares were sold short at the 2026-10-15 settlement, -13.77% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.